Drugs / BAY2413555
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05532046 | Sep 2022 → Mar 2023 | heart failure | Bayer | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BAY2413555 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05532046 ↗ |
| Route | Oral | “take BAY2413555 as a tablet by mouth once per day” NCT05532046 ↗ |